FDA Approves Tirzepatide for Obstructive Sleep Apnea
Episode Summary
Tirzepatide significantly reduced obstructive sleep apnea severity and body weight in adults with obesity, supporting FDA-approved treatment alongside lifestyle changes and PAP therapy.